BAXTER INTERNATIONAL INC (BAX) Stock Fundamental Analysis

USA • New York Stock Exchange • NYSE:BAX • US0718131099

21.305 USD
+0.27 (+1.31%)
Last: Feb 5, 2026, 11:49 AM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to BAX. BAX was compared to 186 industry peers in the Health Care Equipment & Supplies industry. BAX has a medium profitability rating, but doesn't score so well on its financial health evaluation. BAX is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • In the past year BAX was profitable.
  • BAX had a positive operating cash flow in the past year.
  • In multiple years BAX reported negative net income over the last 5 years.
  • Each year in the past 5 years BAX had a positive operating cash flow.
BAX Yearly Net Income VS EBIT VS OCF VS FCFBAX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B 4B

1.2 Ratios

  • With a decent Return On Assets value of -1.62%, BAX is doing good in the industry, outperforming 70.97% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of -4.71%, BAX is in the better half of the industry, outperforming 71.51% of the companies in the same industry.
  • The Return On Invested Capital of BAX (3.04%) is better than 70.97% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for BAX is significantly below the industry average of 8.80%.
Industry RankSector Rank
ROA -1.62%
ROE -4.71%
ROIC 3.04%
ROA(3y)-0.58%
ROA(5y)1.52%
ROE(3y)-6.47%
ROE(5y)1.48%
ROIC(3y)3.5%
ROIC(5y)4.71%
BAX Yearly ROA, ROE, ROICBAX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40

1.3 Margins

  • With a decent Operating Margin value of 6.37%, BAX is doing good in the industry, outperforming 72.04% of the companies in the same industry.
  • BAX's Operating Margin has declined in the last couple of years.
  • BAX has a Gross Margin of 35.04%. This is in the lower half of the industry: BAX underperforms 73.12% of its industry peers.
  • BAX's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 6.37%
PM (TTM) N/A
GM 35.04%
OM growth 3Y-19.11%
OM growth 5Y-13.17%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.94%
GM growth 5Y-2.16%
BAX Yearly Profit, Operating, Gross MarginsBAX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • BAX has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • The number of shares outstanding for BAX has been increased compared to 1 year ago.
  • Compared to 5 years ago, BAX has more shares outstanding
  • Compared to 1 year ago, BAX has a worse debt to assets ratio.
BAX Yearly Shares OutstandingBAX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
BAX Yearly Total Debt VS Total AssetsBAX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

  • An Altman-Z score of 2.27 indicates that BAX is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • With a decent Altman-Z score value of 2.27, BAX is doing good in the industry, outperforming 65.59% of the companies in the same industry.
  • The Debt to FCF ratio of BAX is 38.94, which is on the high side as it means it would take BAX, 38.94 years of fcf income to pay off all of its debts.
  • BAX's Debt to FCF ratio of 38.94 is fine compared to the rest of the industry. BAX outperforms 67.74% of its industry peers.
  • BAX has a Debt/Equity ratio of 1.21. This is a high value indicating a heavy dependency on external financing.
  • BAX has a worse Debt to Equity ratio (1.21) than 76.34% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.21
Debt/FCF 38.94
Altman-Z 2.27
ROIC/WACC0.4
WACC7.66%
BAX Yearly LT Debt VS Equity VS FCFBAX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.3 Liquidity

  • BAX has a Current Ratio of 1.84. This is a normal value and indicates that BAX is financially healthy and should not expect problems in meeting its short term obligations.
  • BAX's Current ratio of 1.84 is on the low side compared to the rest of the industry. BAX is outperformed by 65.05% of its industry peers.
  • A Quick Ratio of 1.18 indicates that BAX should not have too much problems paying its short term obligations.
  • With a Quick ratio value of 1.18, BAX is not doing good in the industry: 67.74% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.84
Quick Ratio 1.18
BAX Yearly Current Assets VS Current LiabilitesBAX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. Growth

3.1 Past

  • The earnings per share for BAX have decreased strongly by -19.93% in the last year.
  • Measured over the past years, BAX shows a decrease in Earnings Per Share. The EPS has been decreasing by -4.21% on average per year.
  • BAX shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -21.20%.
  • BAX shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -1.31% yearly.
EPS 1Y (TTM)-19.93%
EPS 3Y-9.2%
EPS 5Y-4.21%
EPS Q2Q%-13.75%
Revenue 1Y (TTM)-21.2%
Revenue growth 3Y-5.95%
Revenue growth 5Y-1.31%
Sales Q2Q%-26.34%

3.2 Future

  • The Earnings Per Share is expected to grow by 1.85% on average over the next years.
  • Based on estimates for the next years, BAX will show a small growth in Revenue. The Revenue will grow by 2.77% on average per year.
EPS Next Y-11.87%
EPS Next 2Y-8.48%
EPS Next 3Y-3.29%
EPS Next 5Y1.85%
Revenue Next Year4.95%
Revenue Next 2Y3.46%
Revenue Next 3Y3.3%
Revenue Next 5Y2.77%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
BAX Yearly Revenue VS EstimatesBAX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5B 10B 15B
BAX Yearly EPS VS EstimatesBAX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1 2 3

More info and screens

Find the best growth stocksShow best growing peers

6

4. Valuation

4.1 Price/Earnings Ratio

  • BAX is valuated reasonably with a Price/Earnings ratio of 8.84.
  • BAX's Price/Earnings ratio is rather cheap when compared to the industry. BAX is cheaper than 95.70% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of BAX to the average of the S&P500 Index (28.25), we can say BAX is valued rather cheaply.
  • Based on the Price/Forward Earnings ratio of 9.39, the valuation of BAX can be described as reasonable.
  • BAX's Price/Forward Earnings ratio is rather cheap when compared to the industry. BAX is cheaper than 95.70% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 27.50. BAX is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 8.84
Fwd PE 9.39
BAX Price Earnings VS Forward Price EarningsBAX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • BAX's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. BAX is cheaper than 89.25% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of BAX indicates a somewhat cheap valuation: BAX is cheaper than 74.19% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 44.89
EV/EBITDA 11.01
BAX Per share dataBAX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 15 20

4.3 Compensation for Growth

  • BAX's earnings are expected to decrease with -3.29% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-8.48%
EPS Next 3Y-3.29%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

3

5. Dividend

5.1 Amount

  • With a yearly dividend of 0.20%, BAX is not a good candidate for dividend investing.
  • BAX's Dividend Yield is rather good when compared to the industry average which is at 0.21. BAX pays more dividend than 90.32% of the companies in the same industry.
  • With a Dividend Yield of 0.20, BAX pays less dividend than the S&P500 average, which is at 1.82.
Industry RankSector Rank
Dividend Yield 0.2%

5.2 History

  • The dividend of BAX is nicely growing with an annual growth rate of 6.89%!
  • BAX has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)6.89%
Div Incr Years0
Div Non Decr Years0
BAX Yearly Dividends per shareBAX Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

  • BAX has negative earnings and hence a negative payout ratio. The dividend may be in danger.
  • BAX's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP-119.65%
EPS Next 2Y-8.48%
EPS Next 3Y-3.29%
BAX Yearly Income VS Free CF VS DividendBAX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B 4B

More info and screens

Find the best dividend stocksShow peers with best dividend

BAXTER INTERNATIONAL INC

NYSE:BAX (2/5/2026, 11:49:07 AM)

21.305

+0.27 (+1.31%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)10-30
Earnings (Next)02-12
Inst Owners102.74%
Inst Owner Change0.98%
Ins Owners0.28%
Ins Owner Change10.02%
Market Cap10.95B
Revenue(TTM)11.02B
Net Income(TTM)-341.00M
Analysts55.2
Price Target23.74 (11.43%)
Short Float %6.6%
Short Ratio4.11
Dividend
Industry RankSector Rank
Dividend Yield 0.2%
Yearly Dividend1.16
Dividend Growth(5Y)6.89%
DP-119.65%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)4.96%
Min EPS beat(2)-4.25%
Max EPS beat(2)14.16%
EPS beat(4)3
Avg EPS beat(4)8.34%
Min EPS beat(4)-4.25%
Max EPS beat(4)14.16%
EPS beat(8)7
Avg EPS beat(8)5.47%
EPS beat(12)9
Avg EPS beat(12)3.78%
EPS beat(16)11
Avg EPS beat(16)3.66%
Revenue beat(2)0
Avg Revenue beat(2)-1.91%
Min Revenue beat(2)-2.38%
Max Revenue beat(2)-1.44%
Revenue beat(4)2
Avg Revenue beat(4)-0.36%
Min Revenue beat(4)-2.38%
Max Revenue beat(4)1.93%
Revenue beat(8)5
Avg Revenue beat(8)-0.06%
Revenue beat(12)6
Avg Revenue beat(12)-0.48%
Revenue beat(16)6
Avg Revenue beat(16)-2.41%
PT rev (1m)-3.28%
PT rev (3m)-17.71%
EPS NQ rev (1m)0.52%
EPS NQ rev (3m)-23.15%
EPS NY rev (1m)0.04%
EPS NY rev (3m)-3.22%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-6.03%
Revenue NY rev (1m)0.02%
Revenue NY rev (3m)-2.03%
Valuation
Industry RankSector Rank
PE 8.84
Fwd PE 9.39
P/S 0.99
P/FCF 44.89
P/OCF 14.62
P/B 1.51
P/tB N/A
EV/EBITDA 11.01
EPS(TTM)2.41
EY11.31%
EPS(NY)2.27
Fwd EY10.65%
FCF(TTM)0.47
FCFY2.23%
OCF(TTM)1.46
OCFY6.84%
SpS21.44
BVpS14.09
TBVpS-5.77
PEG (NY)N/A
PEG (5Y)N/A
Graham Number27.64
Profitability
Industry RankSector Rank
ROA -1.62%
ROE -4.71%
ROCE 4.06%
ROIC 3.04%
ROICexc 3.37%
ROICexgc 9.79%
OM 6.37%
PM (TTM) N/A
GM 35.04%
FCFM 2.21%
ROA(3y)-0.58%
ROA(5y)1.52%
ROE(3y)-6.47%
ROE(5y)1.48%
ROIC(3y)3.5%
ROIC(5y)4.71%
ROICexc(3y)3.9%
ROICexc(5y)5.53%
ROICexgc(3y)10.35%
ROICexgc(5y)12.85%
ROCE(3y)4.85%
ROCE(5y)6.42%
ROICexgc growth 3Y-24.28%
ROICexgc growth 5Y-17.95%
ROICexc growth 3Y-15.78%
ROICexc growth 5Y-22.54%
OM growth 3Y-19.11%
OM growth 5Y-13.17%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.94%
GM growth 5Y-2.16%
F-Score3
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity 1.21
Debt/FCF 38.94
Debt/EBITDA 5.18
Cap/Depr 51.22%
Cap/Sales 4.58%
Interest Coverage 250
Cash Conversion 44.37%
Profit Quality N/A
Current Ratio 1.84
Quick Ratio 1.18
Altman-Z 2.27
F-Score3
WACC7.66%
ROIC/WACC0.4
Cap/Depr(3y)49.31%
Cap/Depr(5y)63.51%
Cap/Sales(3y)5.12%
Cap/Sales(5y)5.45%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-19.93%
EPS 3Y-9.2%
EPS 5Y-4.21%
EPS Q2Q%-13.75%
EPS Next Y-11.87%
EPS Next 2Y-8.48%
EPS Next 3Y-3.29%
EPS Next 5Y1.85%
Revenue 1Y (TTM)-21.2%
Revenue growth 3Y-5.95%
Revenue growth 5Y-1.31%
Sales Q2Q%-26.34%
Revenue Next Year4.95%
Revenue Next 2Y3.46%
Revenue Next 3Y3.3%
Revenue Next 5Y2.77%
EBIT growth 1Y-43.88%
EBIT growth 3Y-23.92%
EBIT growth 5Y-14.31%
EBIT Next Year53.79%
EBIT Next 3Y17.7%
EBIT Next 5Y17.33%
FCF growth 1Y-73.82%
FCF growth 3Y-27.1%
FCF growth 5Y-16.46%
OCF growth 1Y-54.16%
OCF growth 3Y-22.88%
OCF growth 5Y-13.5%

BAXTER INTERNATIONAL INC / BAX FAQ

What is the fundamental rating for BAX stock?

ChartMill assigns a fundamental rating of 4 / 10 to BAX.


Can you provide the valuation status for BAXTER INTERNATIONAL INC?

ChartMill assigns a valuation rating of 6 / 10 to BAXTER INTERNATIONAL INC (BAX). This can be considered as Fairly Valued.


What is the profitability of BAX stock?

BAXTER INTERNATIONAL INC (BAX) has a profitability rating of 4 / 10.


Can you provide the expected EPS growth for BAX stock?

The Earnings per Share (EPS) of BAXTER INTERNATIONAL INC (BAX) is expected to decline by -11.87% in the next year.


How sustainable is the dividend of BAXTER INTERNATIONAL INC (BAX) stock?

The dividend rating of BAXTER INTERNATIONAL INC (BAX) is 3 / 10 and the dividend payout ratio is -119.65%.